Both in Pharmaceuticals
Lifevantage Corporation Common Stock (Delaware) vs Acrivon Therapeutics
Over the past year LFVN returned −18.1% and ACRV returned −26.2%; their daily moves had a correlation of 0.02.
LFVN −18.1% ACRV −26.2%Growth of $1, one year, split-adjusted
| Metric | LFVN | ACRV |
|---|---|---|
| Price | $6.01 | $1.72 |
| Market cap | $75.7M | $73.7M |
| Today | +4.34% | +2.99% |
| 1 month | −0.5% | −7.5% |
| 6 months | +0.2% | −17.7% |
| Year to date | −2.4% | −28.6% |
| 1 year | −18.1% | −26.2% |
| Revenue growth (YoY) | −23.1% | — |
| Gross margin | 78.0% | — |
| Net margin | 3.0% | — |
| P/E (TTM) | 14.9× | — |
| Price / sales | 0.4× | — |
| Net cash | $14.9M | $90.0M |
| Dividend yield | 3.33% | — |
| Volatility (60d) | 26.5% | 70.8% |
| Short % of float | 9.5% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).